Marc Sanson

30.4k citations
320 papers · 14.2k · 6 hit papers · h-index 61

Impact in

  • Genetics top 0.02%
    • Glioma Diagnosis and Treatment
    • Cancer, Hypoxia, and Metabolism
    • MicroRNA in disease regulation

Papers in

    • Glioma Diagnosis and Treatment 202
    • Epigenetics and DNA Methylation 17
    • Chromatin Remodeling and Cancer 16

Marc Sanson

307 papers receiving 14.0k citations

Marc Sanson's Hit Papers

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study 2021 · 177 citations
1770+6+13Years since publication250500750

Peers

Marc Sanson
Comparison fields: 5 of 139
  • Genetics 8.0k
  • Cancer Research 2.9k
  • Neurology 2.1k
  • Pulmonary and Respiratory Medicine 2.1k
  • Molecular Biology 4.3k
Replace Yingli Wolinsky with:
Yingli Wolinsky United States
Christian Hartmann Germany
Johannes A. Hainfellner Austria
Johan M. Kros Netherlands
Jean‐Yves Delattre France
David Capper Germany
Dominique Figarella‐Branger France
Anne Jouvet France
Karima Mokhtari France
Torsten Pietsch Germany
Marc Sanson relative to Yingli Wolinsky United States Yingli Wolinsky's profile →
Citations per field
00.5×
Yingli Wolinsky · 1×
Citations per year

Countries citing papers authored by Marc Sanson

Since Specialization
Citations

This map shows the geographic impact of Marc Sanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Sanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Sanson more than expected).

Fields of papers citing papers by Marc Sanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Sanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Sanson. The network helps show where Marc Sanson may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Sanson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Sanson Line = papers co-authored together Marc Sanson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 320 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Hit paper breakdown →
2009776
2
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Hit paper breakdown →
2016583
3
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Hit paper breakdown →
2006523
4 2010404
5
MGMT testing—the challenges for biomarker-based glioma treatment
Hit paper breakdown →
2014402
6
Glioblastoma targeted therapy: updated approaches from recent biological insights
Hit paper breakdown →
2017329
7 2010304
8 2010287
9 2004272
10 2008214
11 2002208
12 2009203
13 2014178
14
Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study
Hit paper breakdown →
2021177
15 2012174
16 2006174
17 2010163
18 2006162
19 2012153
20 2007146

About Marc Sanson

Marc Sanson is a scholar working on Genetics, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Neurology, having authored 320 papers that have together received 14.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (202 papers), Meningioma and schwannoma management (38 papers), Neurofibromatosis and Schwannoma Cases (30 papers), Cancer, Hypoxia, and Metabolism (29 papers), Brain Metastases and Treatment (29 papers), MicroRNA in disease regulation (18 papers), Epigenetics and DNA Methylation (17 papers) and Chromatin Remodeling and Cancer (16 papers). The work is most often cited by research in Genetics (8.0k citations), Cancer Research (2.9k citations), Neurology (2.1k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Molecular Biology (4.3k citations). Marc Sanson has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Khê Hoang‐Xuan, Ahmed Idbaïh, Karima Mokhtari, Jean‐Yves Delattre, Yannick Marie, Blandine Boisselier, Florence Laigle–Donadey, Alain Carpentier, Martin J. van den Bent and François Ducray. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Neurology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact